Show simple item record

dc.contributor.authorBlom, Maartje
dc.contributor.authorPico-Knijnenburg, Ingrid
dc.contributor.authorImholz, Sandra
dc.contributor.authorVissers, Lotte
dc.contributor.authorSchulze, Janika
dc.contributor.authorWerner, Jeannette
dc.contributor.authorBredius, Robbert
dc.contributor.authorvan der Burg, Mirjam
dc.date.accessioned2021-09-13T12:44:01Z
dc.date.available2021-09-13T12:44:01Z
dc.date.issued2021-08-09
dc.identifier.pmid34370170
dc.identifier.doi10.1007/s10875-021-01107-2
dc.identifier.urihttp://hdl.handle.net/10029/625254
dc.language.isoenen_US
dc.rights© 2021. The Author(s).
dc.subjectEpigenetic immune cell countingen_US
dc.subjectInborn errors of immunityen_US
dc.subjectNGSen_US
dc.subjectNewborn screeningen_US
dc.subjectNext-generation sequencingen_US
dc.subjectSCIDen_US
dc.subjectSecond tieren_US
dc.subjectSevere combined immunodeficiencyen_US
dc.subjectTRECsen_US
dc.titleSecond Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency.en_US
dc.typeArticleen_US
dc.identifier.eissn1573-2592
dc.identifier.journalJ Clin Immunol 2021; advance online publication (ahead of print)en_US
dc.source.journaltitleJournal of clinical immunology
dc.source.countryNetherlands
dc.source.countryNetherlands


This item appears in the following Collection(s)

Show simple item record